Hepatitis A

Hepatitis A is characterized by inflammation of the liver due to infection with the hepatitis A virus (HAV). While some individuals may experience only mild symptoms lasting a few weeks, others may face more severe complications that persist for months. In rare cases, though, hepatitis A can be severe and cause liver damage or liver failure.

Browse all Hepatitis A products

HAV Replication and Immune Response

Adsorption and penetration: HAV binds to receptors on the host cell surface through its surface antigen VP1, and then adsorption occurs. Subsequently, the virus enters the host cell through endocytosis.

Uncoating: In host cells, HAV particles are induced by the acidic environment of lysosomes in endocytoses, leading to the uncoating of the virus particles. After uncoating, the virus releases its RNA genome.

Replication: The RNA genome of HAV serves as a template to synthesize new viral RNA molecules through the participation of ribosomes and enzymes in the host cell. These newly synthesized RNA molecules can further serve as templates to synthesize more viral RNA.

Assembly: The newly synthesized viral RNA molecules will combine with the structural proteins VP1, VP2, VP3, and VP4 in the viral particles to form new viral particles. These viral particles aggregate within host cells to form viral colonies.

Release: Finally, the newly synthesized virus particles are released outside the host body through cell lysis or secretory pathways. These virus particles can further spread to other tissues and organs through the blood circulation.

Immune Response: As HAV replicates in the liver, the immune system recognizes the presence of the virus and mounts an immune response. The immune response involves the activation of various immune cells, including T cells and B cells. T cells, specifically CD8+ T cells, play a crucial role in clearing the virus by directly killing infected hepatocytes. B cells produce antibodies that can neutralize the virus and help in its elimination. The immune response leads to the production of specific antibodies against HAV, which can provide long-term immunity.

Hepatitis A Test

Hepatitis A testing is a crucial diagnostic tool used to identify and confirm the presence of HAV infection in individuals. It involves various tests that detect specific antibodies or the genetic material of the virus. Some key details about hepatitis A testing include:

• Hepatitis A Immunoglobulin M (IgM Anti-HAV) Antibody Test
  • This test is commonly used to diagnose acute or recent hepatitis A infection.
  • IgM antibodies are produced by the immune system in response to the initial HAV infection.
  • The test detects the presence of IgM anti-HAV antibodies in the blood.
  • IgM antibodies are typically detectable within two weeks after symptoms appear and can persist for up to six months.
  • A positive IgM anti-HAV result indicates ongoing or recent hepatitis A infection.

• Hepatitis A Immunoglobulin G (IgG Anti-HAV) Antibody Test
  • The IgG anti-HAV antibody test is used to detect past HAV infections and determine immunity.
  • IgG antibodies develop later in the course of the disease and provide long-term protection against future hepatitis A infections.
  • IgG antibodies can be detected in the body for life.
  • This test is helpful in identifying individuals who have been previously infected or have received hepatitis A vaccination.
  • A positive IgG anti-HAV result indicates past infection or immunity.

• Total Hepatitis A Antibody Test
  • The total HAV antibody test detects both IgM and IgG antibodies in the blood.
  • It is used to identify both current and past infections.
  • This test provides a comprehensive assessment of the body's immune response to HAV.

• Nucleic Acid Amplification Testing (NAAT)
  • NAAT is a molecular diagnostic test that detects the genetic material (RNA) of HAV.
  • It can be performed on various samples such as blood, stool, body fluids, or liver tissue.
  • NAAT is highly sensitive and specific, allowing for the detection of even small amounts of the virus.
  • This testing method is particularly useful in confirming the presence of HAV in cases where antibody testing may yield false-negative results.

HAV-Related Antibodies

HAV-Related Antigens

HAV-Related ELISA Kits